RESMED INC - Common Stock (RMD) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
RMD on NYSE
Shares outstanding
146,467,184
Price per share
$240.87
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
91,409,394
Total reported value
$25,012,257,351
% of total 13F portfolios
0.02%
Share change
-643,530
Value change
-$151,720,217
Number of holders
931
Price from insider filings
$240.87
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of RESMED INC - Common Stock (RMD) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
VANGUARD GROUP INC 14% $5,476,630,365 20,007,417 The Vanguard Group 30 Sep 2025

As of 30 Sep 2025, 931 institutional investors reported holding 91,409,394 shares of RESMED INC - Common Stock (RMD). This represents 62% of the company’s total 146,467,184 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of RESMED INC - Common Stock (RMD) together control 45% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
VANGUARD GROUP INC 13% 19,040,440 +1.6% 0.08% $5,211,939,642
BlackRock, Inc. 8.4% 12,277,966 -1.3% 0.06% $3,360,847,519
STATE STREET CORP 4.5% 6,549,164 -1% 0.06% $1,792,702,662
Bank of New York Mellon Corp 3.1% 4,552,916 -9.8% 0.22% $1,246,269,745
GEODE CAPITAL MANAGEMENT, LLC 2.9% 4,251,688 +0.87% 0.07% $1,159,544,500
MORGAN STANLEY 1.6% 2,313,138 -13% 0.04% $633,175,806
Invesco Ltd. 1.4% 2,108,763 -3.4% 0.09% $577,231,572
NORTHERN TRUST CORP 1.2% 1,697,882 -1% 0.06% $464,761,240
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.73% 1,067,643 +4.6% 0.05% $292,245,918
Legal & General Group Plc 0.65% 958,210 -1.4% 0.06% $262,290,821
UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC 0.62% 906,744 -13% 0.05% $248,203,036
FMR LLC 0.6% 880,306 +155% 0.01% $240,965,941
UBS Group AG 0.6% 873,530 +64% 0.05% $239,111,367
GOLDMAN SACHS GROUP INC 0.59% 860,791 +3.2% 0.03% $235,624,329
DIMENSIONAL FUND ADVISORS LP 0.58% 846,134 +6.2% 0.05% $231,586,653
BANK OF AMERICA CORP /DE/ 0.56% 823,624 -2.3% 0.02% $225,450,507
NORDEA INVESTMENT MANAGEMENT AB 0.54% 790,872 +3.5% 0.19% $217,386,987
PRICE T ROWE ASSOCIATES INC /MD/ 0.53% 772,187 +125% 0.02% $211,372,000
ROYAL BANK OF CANADA 0.48% 706,369 +35% 0.03% $193,354,000
DEUTSCHE BANK AG\ 0.43% 625,528 +23% 0.06% $171,225,780
JPMORGAN CHASE & CO 0.42% 617,464 +16% 0.01% $169,027,458
BARCLAYS PLC 0.4% 579,632 -22% 0.06% $158,662,667
Caisse de depot et placement du Quebec 0.39% 565,901 +28% 0.28% $154,904,079
Swedbank AB 0.37% 542,711 +25% 0.15% $148,556,281
CAPTRUST FINANCIAL ADVISORS 0.37% 537,623 +5.4% 0.3% $147,163,581

Institutional Holders of RESMED INC - Common Stock (RMD) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 1,600,368 $386,688,468 +$70,699,108 $240.87 46
2025 Q3 91,409,394 $25,012,257,351 -$151,720,217 $273.73 931
2025 Q2 92,309,428 $23,802,163,537 -$234,889,533 $258.00 911
2025 Q1 93,341,270 $20,873,665,746 +$659,205,153 $223.85 872
2024 Q4 90,103,150 $20,611,027,939 +$523,118,005 $228.69 863
2024 Q3 86,823,807 $21,178,183,309 +$357,448,956 $244.12 792
2024 Q2 85,413,001 $16,344,246,847 +$454,535,216 $191.42 768
2024 Q1 82,914,769 $16,411,147,126 +$513,359,778 $198.03 710
2023 Q4 80,394,822 $13,829,283,421 -$1,271,808,453 $172.02 680
2023 Q3 87,735,817 $12,964,369,891 -$1,617,256,395 $147.87 648
2023 Q2 95,075,328 $20,771,183,152 -$111,688,592 $218.50 724
2023 Q1 95,323,306 $20,870,559,574 +$76,827,102 $218.99 665
2022 Q4 95,570,997 $19,893,153,622 -$213,631,417 $208.13 717
2022 Q3 96,528,325 $21,085,043,390 -$40,809,623 $218.30 650
2022 Q2 96,423,808 $20,247,886,410 -$216,827,167 $209.63 661
2022 Q1 97,272,612 $23,607,128,509 +$638,048,061 $242.51 658
2021 Q4 94,533,097 $24,611,319,237 -$550,619,558 $260.48 703
2021 Q3 96,265,199 $25,370,506,829 -$115,406,017 $263.55 673
2021 Q2 96,700,199 $23,835,730,320 -$548,687,648 $246.52 650
2021 Q1 99,033,646 $19,213,495,080 -$384,053,397 $194.02 649
2020 Q4 101,297,957 $21,523,684,165 +$125,179,911 $212.56 652
2020 Q3 100,513,676 $17,230,325,953 -$286,391,481 $171.43 612
2020 Q2 102,006,987 $19,585,421,181 +$701,386,093 $192.00 567
2020 Q1 98,435,082 $14,502,972,264 +$119,165,301 $147.29 574
2019 Q4 97,640,442 $15,128,001,356 +$142,829,575 $154.97 551
2019 Q3 96,630,375 $13,051,505,290 +$38,434,738 $135.11 514
2019 Q2 96,365,742 $11,754,959,118 +$23,486,040 $122.03 475
2019 Q1 97,619,409 $10,147,859,923 -$14,207,588 $103.97 468
2018 Q4 97,569,996 $11,099,337,871 +$397,513,543 $113.87 489
2018 Q3 94,081,151 $10,848,844,708 +$178,170,189 $115.34 486
2018 Q2 92,503,328 $9,581,445,253 +$226,242,346 $103.58 455
2018 Q1 90,228,934 $8,883,079,877 +$143,625,612 $98.47 435
2017 Q4 89,322,328 $7,564,180,997 +$29,233,715 $84.69 410
2017 Q3 88,883,200 $6,839,668,471 +$166,333,622 $76.96 359
2017 Q2 86,773,703 $6,755,702,862 +$42,211,359 $77.87 335
2017 Q1 86,833,338 $6,248,639,244 +$813,666,355 $71.97 368
2016 Q4 88,072,867 $5,464,641,164 -$131,915,963 $62.05 356
2016 Q3 89,994,221 $5,828,633,461 +$197,606,819 $64.79 368
2016 Q2 86,958,278 $5,499,043,282 +$226,844,283 $63.23 355
2016 Q1 83,494,592 $4,825,081,452 +$24,464,544 $57.82 365
2015 Q4 82,814,635 $4,446,599,092 +$286,786,392 $53.69 346
2015 Q3 77,270,412 $3,927,210,578 +$122,197,423 $50.96 310
2015 Q2 74,586,620 $4,203,538,985 +$12,963,111 $56.37 310
2015 Q1 73,509,048 $5,271,836,683 -$59,419,105 $71.78 323
2014 Q4 74,749,965 $4,194,016,041 +$85,626,962 $56.06 302
2014 Q3 72,751,035 $3,584,815,417 -$144,765,288 $49.27 297
2014 Q2 75,588,962 $3,827,465,671 -$207,528,760 $50.63 308
2014 Q1 80,134,321 $3,581,405,050 +$1,484,371 $44.69 314